These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33911018)

  • 1. ATP Release Drives Inflammation with Lysophosphatidylcholine.
    Ismaeel S; Qadri A
    Immunohorizons; 2021 Apr; 5(4):219-233. PubMed ID: 33911018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophospholipids and ATP mutually suppress maturation and release of IL-1 beta in mouse microglial cells using a Rho-dependent pathway.
    Takenouchi T; Iwamaru Y; Sugama S; Sato M; Hashimoto M; Kitani H
    J Immunol; 2008 Jun; 180(12):7827-39. PubMed ID: 18523246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylcholine Promotes Phagosome Maturation and Regulates Inflammatory Mediator Production Through the Protein Kinase A-Phosphatidylinositol 3 Kinase-p38 Mitogen-Activated Protein Kinase Signaling Pathway During
    Lee HJ; Ko HJ; Song DK; Jung YJ
    Front Immunol; 2018; 9():920. PubMed ID: 29755479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidylcholine stimulates IL-1beta release from microglia via a P2X7 receptor-independent mechanism.
    Stock C; Schilling T; Schwab A; Eder C
    J Immunol; 2006 Dec; 177(12):8560-8. PubMed ID: 17142754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-κB translocation and MAPK/ERK phosphorylation.
    Carneiro AB; Iaciura BM; Nohara LL; Lopes CD; Veas EM; Mariano VS; Bozza PT; Lopes UG; Atella GC; Almeida IC; Silva-Neto MA
    PLoS One; 2013; 8(9):e76233. PubMed ID: 24312681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages.
    Olofsson KE; Andersson L; Nilsson J; Björkbacka H
    Biochem Biophys Res Commun; 2008 May; 370(2):348-52. PubMed ID: 18371300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine.
    Domeij H; Hua X; Su J; Bäcklund A; Yan Z; Frostegård AG; Haeggström JZ; Modéer T; Frostegård J
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():72-8. PubMed ID: 23391726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylcholine induces adenosine release from macrophages via TRPM7-mediated mitochondrial activation.
    Youssef AM; Song DK
    Purinergic Signal; 2022 Sep; 18(3):317-343. PubMed ID: 35779163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidylcholine induces expression of genes involved in cholesterol biosynthesis in THP-1 derived macrophages.
    Cha MH; Lee SM; Jung J
    Steroids; 2018 Nov; 139():28-34. PubMed ID: 30217786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stearoyl Lysophosphatidylcholine Inhibits Endotoxin-Induced Caspase-11 Activation.
    Li W; Zhang W; Deng M; Loughran P; Tang Y; Liao H; Zhang X; Liu J; Billiar TR; Lu B
    Shock; 2018 Sep; 50(3):339-345. PubMed ID: 28991049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of P2X(7) receptor by ATP plays an important role in regulating inflammatory responses during acute viral infection.
    Lee BH; Hwang DM; Palaniyar N; Grinstein S; Philpott DJ; Hu J
    PLoS One; 2012; 7(4):e35812. PubMed ID: 22558229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ERK1/2 activation and nNOS uncoupling on endothelial dysfunction induced by lysophosphatidylcholine.
    Campos-Mota GP; Navia-Pelaez JM; Araujo-Souza JC; Stergiopulos N; Capettini LSA
    Atherosclerosis; 2017 Mar; 258():108-118. PubMed ID: 28235709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.
    He Y; Franchi L; Núñez G
    J Immunol; 2013 Jan; 190(1):334-9. PubMed ID: 23225887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages.
    Watanabe S; Usui-Kawanishi F; Karasawa T; Kimura H; Kamata R; Komada T; Inoue Y; Mise N; Kasahara T; Takahashi M
    J Cell Physiol; 2020 Oct; 235(10):7554-7566. PubMed ID: 32115713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells.
    Takenouchi T; Sato M; Kitani H
    J Neurochem; 2007 Sep; 102(5):1518-1532. PubMed ID: 17437542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSG attenuates LPC-induced endothelial cells inflammatory damage through notch signaling inhibition.
    Zhao J; Liang Y; Song F; Xu S; Nian L; Zhou X; Wang S
    IUBMB Life; 2016 Jan; 68(1):37-50. PubMed ID: 26662286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different cytotoxic injuries induced by lysophosphatidylcholine and 7-ketocholesterol in mouse endothelial cells.
    Zhou L; Shi M; Guo Z; Brisbon W; Hoover R; Yang H
    Endothelium; 2006; 13(3):213-26. PubMed ID: 16840177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidylcholine induces glial cell activation: role of rho kinase.
    Sheikh AM; Nagai A; Ryu JK; McLarnon JG; Kim SU; Masuda J
    Glia; 2009 Jun; 57(8):898-907. PubMed ID: 19115379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines.
    Murugesan G; Sandhya Rani MR; Gerber CE; Mukhopadhyay C; Ransohoff RM; Chisolm GM; Kottke-Marchant K
    J Mol Cell Cardiol; 2003 Nov; 35(11):1375-84. PubMed ID: 14596794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial lipase (EL) and EL-generated lysophosphatidylcholines promote IL-8 expression in endothelial cells.
    Riederer M; Lechleitner M; Hrzenjak A; Koefeler H; Desoye G; Heinemann A; Frank S
    Atherosclerosis; 2011 Feb; 214(2):338-44. PubMed ID: 21130993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.